Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster of H5N1 Pandemic Vaccine (GSK1562902A) in Adults
NCT00506350Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2007
- Primary completion
- Oct 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Adjupanrix, sponsored by GSK. Started Aug 2007; status: completed.
02
Drugs
Adjupanrix
Beyond the preview
Go deeper on NCT00506350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00506350.